Pluss Advanced Technologies

A cooling device that can used to induce therapeutic hypothermia.

Content Partner:

Product description Brand name and product description

MiraCradle™ – Neonate Cooler is a passive cooling device which uses savE® phase change material (PCM) technology to induce therapeutic hypothermia among newborns suffering from birth asphyxia.

Target region(s) Target region for distribution/implementation (listed by country if specified)

The company is focused on India as its primary market, but also has plans underway to distribute the device to hospitals in Kenya and South Africa, with contacts listed for distributors in both as of July 2016. It also sees a market for smaller hospitals and clinics in the U.S. and Europe that are looking for low-cost alternatives to higher cost alternatives for hypothermia treatment systems that are currently available.

Distributors/implementing organizations Organization(s) distributing/deploying this product directly to communities/individuals?"

The product has distributors for South Africa, Kenya, and specific states in India which can be found here.

Market suggested retail price Price per unit or service price per usage/terms (USD). Subsidies noted.

$3558 USD as of July 2016 (conversion from 240,000 Indian rupees)

Designer Pluss Advanced Technologies priced the neonatal cooling bed at 240,000 Indian rupees, or about $4,000 USD. This price is roughly 1/10th that of alternative technologies currently available in India.

Competitive landscape Similar products available on the market. May not be a comprehensive listing.

Electronic instruments, frozen gel/ice packs

In the Indian market specifically, the available alternatives to treat birth asphyxia are relatively expensive electronic instruments. These cost approximately Rs 15 lakhs (1,500,000 Rupees) and are often not affordable for most hospital.

SDG targeted United Nations Sustainable Development Goals (SDGs) targeted with this product/application/service

Goal 3: to improve and promote good health.

Birth asphyxia is the medical condition resulting from lack of oxygen in a newborn infant. It is a major cause of Hypoxic Ischemic Encephalothapy and consequential brain damage or even death. Therapeutic hypothermia induced by cooling to around 33 °C for three days after birth is the prescribed treatment.

The World Health Organization estimates that 650,000 babies worldwide die from birth asphyxia each year, though the number of annual instances is notoriously underreported, especially for children who survive. The overwhelming majority of cases—more than 95 percent—occur in less-developed parts of the world. Many mothers from these areas lack access to skilled medical care during pregnancy and childbirth.

Target user(s) Target user/consumer base (country, income segment)

MiraCradle should be operated by or under the supervision of a medically trained person who is well-versed in the concept of neonatal care and understands the sensitivities for treatment of such newborns.

The @AutodeskFdn blogged about our how-to guide for communities writing proposals for development projects https://t.co/MlRH1H0x2F